TRAF2 and neoplasm: To further explore the molecular mechanisms driving tumor sensitivity to CD8 T cell-mediated killing, we challenged wild-type (WT) and TRAF2 knockout (KO) melanoma cells with healthy donor CD8 T cells using a matched co-culture system.